Financial reports - Theratechnologies, TSX TH, Tesamorelin, Lipohypertrophy, Lipodystrophy treatment

Model and picture are being used for illustrative purposes only.

Products developed by Theratechnologies target unmet medical needs in commercially attractive specialty markets.

Investor Relations

2007 Annual Report

2007 Annual Report

2007 Annual Report - COMPLETE (PDF: 1.2 Mb)
2007 Highlights and Corporate Overview (PDF: 1 Mb)
Message to Shareholders (PDF: 68 Kb)
Chairman’s Letter (PDF: 52 Kb)
Management’s Discussion and Analysis (PDF: 168 Kb)
Auditors’ Report and Financial Statements (PDF: 136 Kb)
Financial Statements (MS Excel: 52 Kb)

Terms of use